Identification of novel Adefovir (cas 106941-25-7) dipivoxil-saccharin cocrystal polymorphs and their thermodynamic polymorphic transformations
-
Add time:08/06/2019 Source:sciencedirect.com
In this paper, two novel polymorphs of Adefovir (cas 106941-25-7) dipivoxil-saccharin (AD-SAC) cocrystals, forms II and III, were prepared and characterized by PXRD, DSC, FT-IR and SEM. Polymorphic transformations of these two forms and the known form (form I) were also investigated. In comparison to form I, forms II and III of AD-SAC cocrystals showed different thermal behaviors on DSC, characteristic diffraction peaks on PXRD and absorption spectra on FT-IR. In addition, form I exhibited an irregular plate-like shape, while forms II and III showed as needle-like shape and stubby columnar shape, respectively. During the heating process on DSC, forms I and II underwent solid-solid transformations to form III with endothermic transition peaks, suggesting that forms I and II were enantiotropically related to form III. Furthermore, slurry conversion experiments in ethanol showed forms II and III would quickly convert to form I by solution-mediated transformation, indicating that form I was the most stable form among three forms of AD-SAC cocrystal from 15 to 50 °C.
We also recommend Trading Suppliers and Manufacturers of Adefovir (cas 106941-25-7). Pls Click Website Link as below: cas 106941-25-7 suppliers
Prev:Pretreatment of bamboo shoot shell with surfactant OP-10 in the acidified media for enhancing the biosynthesis of ethyl (S)-4-chloro-3-hydroxybutanoate
Next:Synthesis, pharmacological evaluation, and mechanistic study of Adefovir (cas 106941-25-7) mixed phosphonate derivatives bearing cholic acid and l) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Injectable PLGA Adefovir (cas 106941-25-7) microspheres; the way for long term therapy of chronic hepatitis-B08/11/2019
- Monotherapy with tenofovir disoproxil fumarate for Adefovir (cas 106941-25-7)-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial08/10/2019
- Adefovir (cas 106941-25-7) dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction08/09/2019
- Effect of nonalcoholic steatohepatitis on renal filtration and secretion of Adefovir (cas 106941-25-7)08/08/2019
- Synthesis, pharmacological evaluation, and mechanistic study of Adefovir (cas 106941-25-7) mixed phosphonate derivatives bearing cholic acid and l08/07/2019